Atnaujinkite slapukų nuostatas

Transmissible Diseases and Blood Transfusion: Proceedings of the Twenty-Sixth International Symposium on Blood Transfusion, Groningen, NL, Organized by the Sanquin Division Blood Bank Noord Nederland 2002 ed. [Kietas viršelis]

Edited by , Edited by
  • Formatas: Hardback, 220 pages, aukštis x plotis: 235x155 mm, weight: 1120 g, XII, 220 p., 1 Hardback
  • Serija: Developments in Hematology and Immunology 37
  • Išleidimo metai: 30-Sep-2002
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1402009860
  • ISBN-13: 9781402009860
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 220 pages, aukštis x plotis: 235x155 mm, weight: 1120 g, XII, 220 p., 1 Hardback
  • Serija: Developments in Hematology and Immunology 37
  • Išleidimo metai: 30-Sep-2002
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1402009860
  • ISBN-13: 9781402009860
Kitos knygos pagal šią temą:
This late 2001 symposium brought together blood supply managers from Europe and the United States to discuss issues of transmissible disease and other issues related to safety in blood transfusion. Disease topics examined include bacterial contamination, the transmission of parasites, and prion diseases. Among the other topics explored were blood transfusion quality management, the impact of donor selection, and bacterial detection technology. Annotation (c) Book News, Inc., Portland, OR (booknews.com)

This book is the only published literature that comprehensively discusses all aspects of transfusion of transmissible diseases, the facts and the fiction. It is of paramount importance to all involved in the vein to vein chain of transfusion medicine. Session I addresses the basic blood safety aspects including the need for quality management, rational donor screening and the risks of blood transfusion for prenatal developmental toxicity. Session II addresses the gamma of transmissible infectious agents from bacteria through parasites and tick-borne agents to prions and the risks associated with xeno-transplantation and xenozoonoses Session III sheds new light on NAT technology for detection of viral DNA and RNA, the cost-effectiveness of the alternatives to allogeneic blood transfusion. To what extent are genetic defects in stem cell genomic structures transmissible through transplantation and does questioning potential donors make any sense? Session IV addresses the preventive aspects on the future of transfusion medicine. Quantitative real-time PCR for Parvo B19 and advances in bacterial detection technology. The advancement from theory to practice of pathogen inactivation technology based on destruction of nucleic acids in cellular structures. Finally, a plea is made for co-operation and collaboration on a global scale, changing the pars pro toto phenomenon (the ships that pass in the night) for a totum pro parte, a true joining of forces to create a global network for blood safety and structured blood supply systems. Transmissible Diseases and Blood Transfusion is an important reference for all hematologists and researchers involved in transfusion medicine.
Moderators and Speakers xi
Foreword xiii
I. BLOOD SAFETY ASPECTS
Germs, Gels and Genomes. A Personal Recollection of 30 Years in Blood Safety Testing
3(18)
R.Y. Dodd
Quality Management for Blood Transfusion Services
21(2)
G. Vercauteren
The Value of Donor Selection for Blood Safety
23(2)
C.L. van der Poel
Blood Donation; A Risk for Prenatal Developmental Toxicity?
25(26)
P.W.J. Peters
Discussion
39(12)
II. TRANSMISSIBLE DISEASES
Bacterial Contamination of Blood and Blood Products. An Underestimated Problem
51(6)
J.H. Marcelis
Parasites Transmitted by Blood Transfusion
57(16)
L.M. Kortbeek
Prion Diseases and Blood Transfusion
73(10)
M.L. Turner
Tick-Borne Diseases: Recognized and Theoretical Risks Associated with Blood Transfusion
83(10)
D.A. Leiby
Xeno-Transplantation and Xenozoonoses
93(18)
E.J. Ruitenberg
Discussion
99(12)
III. TRANSMISSIBLE DISEASES
NAT Update; Where Are We Today?
111(20)
S.L. Stramer
Cost-Effectiveness of Alternatives to Allogeneic Blood Transfusion; Reviewing the Available Evidence
131(12)
M.J. Postma
Hereditary Metabolic Diseases and Stem Cell Transplantation
143(4)
G.P.A. Smit
Detection of Disease: Possibilities and Limitations
147(20)
J.Th.M. de Wolf
Discussion
153(14)
IV. PREVENTATIVE ASPECTS
Quantitative Real-Time PCR for Detection of Parvovirus B19 DNA in Blood Plasma for Plasma Screening
167(10)
H.T.M. Cuypers
Advances in Bacterial Detection Technology
177(4)
W.P.A. van der Tuuk Adriani
Pathogen Inactivated Blood Components: Advancing from Theory to Practice
181(14)
D.S. Wages
GCBS, ICBS and Other Initiatives -- The Pars Pro Toto Phenomenon; Will There Ever Be a Totum Pro Parte?
195(18)
C.Th. Smit Sibinga
Discussion
203(10)
Index 213